Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
Crossref DOI link: https://doi.org/10.2337/dc14-0876
Published Online: 2014-09-10
Published Print: 2014-10-01
Update policy: https://doi.org/10.2337/ada-journal-policies
Diamant, Michaela
Nauck, Michael A.
Shaginian, Rimma
Malone, James K.
Cleall, Simon
Reaney, Matthew
de Vries, Danielle
Hoogwerf, Byron J.
MacConell, Leigh
Wolffenbuttel, Bruce H.R.
,
